Patent Assignment
Reel/Frame 045982/0200
Assignment of Assignor's Interest
Recorded: 2018-06-04
Pages: 3
Assignee
IMMUNOMEDICS, INC.
300 AMERICAN ROAD, MORRIS PLAINS, NEW JERSEY, 07950
Covered Property
(1)
Treatment of High Trop-2 Expressing Triple Negative Breast Cancer (Tnbc) with Sacituzumab Govitecan (Immu-132) Overcomes Homologous Recombination Repair (Hrr) Rescue Mediated by RAD51